- Home
- ADCT vs HNVR Comparison
ADCT vs HNVR Comparison
Compare ADCT & HNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- HNVR
- Stock Information
- Founded
- ADCT 2011
- HNVR 2008
- Country
- ADCT Switzerland
- HNVR United States
- Employees
- ADCT N/A
- HNVR N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- HNVR Commercial Banks
- Sector
- ADCT Health Care
- HNVR Finance
- Exchange
- ADCT Nasdaq
- HNVR Nasdaq
- Market Cap
- ADCT 127.9M
- HNVR 143.6M
- IPO Year
- ADCT 2020
- HNVR 2022
- Fundamental
- Price
- ADCT $1.28
- HNVR $23.11
- Analyst Decision
- ADCT Strong Buy
- HNVR Buy
- Analyst Count
- ADCT 5
- HNVR 1
- Target Price
- ADCT $7.75
- HNVR $22.00
- AVG Volume (30 Days)
- ADCT 235.3K
- HNVR 27.4K
- Earning Date
- ADCT 05-14-2025
- HNVR 04-23-2025
- Dividend Yield
- ADCT N/A
- HNVR 1.73%
- EPS Growth
- ADCT N/A
- HNVR N/A
- EPS
- ADCT N/A
- HNVR 1.30
- Revenue
- ADCT $70,837,000.00
- HNVR $65,041,000.00
- Revenue This Year
- ADCT $6.82
- HNVR N/A
- Revenue Next Year
- ADCT $18.56
- HNVR $15.80
- P/E Ratio
- ADCT N/A
- HNVR $17.77
- Revenue Growth
- ADCT 1.84
- HNVR 1.13
- 52 Week Low
- ADCT $1.05
- HNVR $15.92
- 52 Week High
- ADCT $4.83
- HNVR $27.14
- Technical
- Relative Strength Index (RSI)
- ADCT 43.00
- HNVR 56.86
- Support Level
- ADCT $1.23
- HNVR $22.37
- Resistance Level
- ADCT $1.49
- HNVR $23.94
- Average True Range (ATR)
- ADCT 0.08
- HNVR 0.77
- MACD
- ADCT 0.00
- HNVR 0.12
- Stochastic Oscillator
- ADCT 25.00
- HNVR 74.93
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).
About HNVR Hanover Bancorp Inc.
Hanover Bancorp Inc is a United States-based banking company. It offers a full range of financial services and employs a complete suite of consumer and commercial banking products and services, including multi-family and commercial mortgages, residential loans, business loans, and lines of credit.